Our top pick for
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Onconova Therapeutics Inc. Warrants is an other business based in the US. Onconova Therapeutics IncWarrants shares (ONTXW) are listed on the NASDAQ and all prices are listed in US Dollars.
Since the stock market crash in March caused by coronavirus, Onconova Therapeutics IncWarrants's share price has had significant negative movement.
Its last market close was USD$0.0451, which is 70.52% down on its pre-crash value of USD$0.153 and 35.03% up on the lowest point reached during the March crash when the shares fell as low as USD$0.0334.
If you had bought USD$1,000 worth of Onconova Therapeutics IncWarrants shares at the start of February 2020, those shares would have been worth USD$925.42 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth USD$382.20.
|Latest market close||USD$0.0451|
|52-week range||USD$0.0089 - USD$0.21|
|50-day moving average||USD$0|
|Wall St. target price||N/A|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$-2.7824|
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2020-11-13)||0.0451|
|1 month (2020-10-23)||-14.10%|
|3 months (2020-08-21)||-60.71%|
|6 months (2020-05-22)||-59.00%|
|1 year (2019-11-22)||351.00%|
|2 years (2018-11-20)||N/A|
|3 years (2017-11-21)||-91.54%|
|5 years (2015-11-20)||N/A|
|Gross profit TTM||USD$0|
|Return on assets TTM||0%|
|Return on equity TTM||0%|
TTM: trailing 12 months
We're not expecting Onconova Therapeutics IncWarrants to pay a dividend over the next 12 months.
Everything we know about the Qilian International Holding Group IPO, plus information on how to buy in.
Everything we know about the AbCellera Biologics IPO, plus information on how to buy in.
Steps to owning and managing CALM, with 24-hour and historical pricing before you buy.
Steps to owning and managing CRR, with 24-hour and historical pricing before you buy.
Steps to owning and managing BG, with 24-hour and historical pricing before you buy.
Steps to owning and managing BCLI, with 24-hour and historical pricing before you buy.
Steps to owning and managing BLBD, with 24-hour and historical pricing before you buy.
Steps to owning and managing BDTX, with 24-hour and historical pricing before you buy.
Steps to owning and managing RILYO, with 24-hour and historical pricing before you buy.
Steps to owning and managing ASPN, with 24-hour and historical pricing before you buy.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.